China Resources Double-Crane Pharmaceutical Co Ltd Free Cash Flow Generation Index
China Resources Double-Crane Pharmaceutical Co Ltd free cash flow generation index. China Resources Double-Crane Pharmaceutical Co Ltd (600062) has a Free Cash Flow Generation Index of 0.61x as of September 2025. Free cash flow of CN¥295.62 Million represents 1% of operating cash flow (CN¥487.90 Million). Check China Resources Double-Crane Pharmaceuti (600062) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of China Resources Double-Crane Pharmaceutical Co Ltd (1999–2024)
Free cash flow generation index of China Resources Double-Crane Pharmaceutical Co Ltd from 1999 to 2024. Historical FCF Generation Index trend for China Resources Double-Crane Pharmaceutical Co Ltd across 26 annual periods. Explore 600062 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
China Resources Double-Crane Pharmaceutical Co Ltd Free Cash Flow Generation Index by Year (1999–2024)
China Resources Double-Crane Pharmaceutical Co Ltd free cash flow generation index by year from 1999 to 2024. Year-by-year Free Cash Flow Generation Index for China Resources Double-Crane Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see China Resources Double-Crane Pharmaceuti cash flow conversion.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.65x | CN¥1.19 Billion | CN¥1.83 Billion | CN¥637.50 Million | ▲ +4.7% |
| 2023 | 0.62x | CN¥1.03 Billion | CN¥1.65 Billion | CN¥614.31 Million | ▲ +2.2% |
| 2022 | 0.61x | CN¥816.14 Million | CN¥1.34 Billion | CN¥525.53 Million | ▼ -4.0% |
| 2021 | 0.63x | CN¥849.25 Million | CN¥1.34 Billion | CN¥491.67 Million | ▼ -14.9% |
| 2020 | 0.74x | CN¥1.01 Billion | CN¥1.36 Billion | CN¥348.09 Million | ▼ -10.6% |
| 2019 | 0.83x | CN¥1.20 Billion | CN¥1.44 Billion | CN¥241.65 Million | ▼ -1.4% |
| 2018 | 0.84x | CN¥1.24 Billion | CN¥1.47 Billion | CN¥228.69 Million | ▼ -2.9% |
| 2017 | 0.87x | CN¥1.03 Billion | CN¥1.19 Billion | CN¥154.82 Million | ▲ +1.4% |
| 2016 | 0.86x | CN¥661.20 Million | CN¥771.25 Million | CN¥110.04 Million | ▲ +12.8% |
| 2015 | 0.76x | CN¥532.86 Million | CN¥701.35 Million | CN¥168.49 Million | ▼ -5.2% |
| 2014 | 0.80x | CN¥576.00 Million | CN¥718.38 Million | CN¥142.38 Million | ▲ +33.3% |
| 2013 | 0.60x | CN¥328.56 Million | CN¥546.24 Million | CN¥217.68 Million | ▲ +36.8% |
| 2012 | 0.44x | CN¥174.16 Million | CN¥396.05 Million | CN¥221.89 Million | ▲ +30.2% |
| 2011 | 0.34x | CN¥172.74 Million | CN¥511.53 Million | CN¥338.78 Million | ▲ +23.4% |
| 2010 | 0.27x | CN¥139.50 Million | CN¥509.67 Million | CN¥370.18 Million | ▲ +64.6% |
| 2009 | 0.17x | CN¥56.85 Million | CN¥342.01 Million | CN¥285.16 Million | ▲ +145.0% |
| 2008 | 0.07x | CN¥22.51 Million | CN¥331.71 Million | CN¥309.20 Million | ▼ -83.9% |
| 2007 | 0.42x | CN¥99.29 Million | CN¥235.46 Million | CN¥136.17 Million | ▼ -3.0% |
| 2006 | 0.43x | CN¥132.05 Million | CN¥303.71 Million | CN¥171.66 Million | ▲ +380.8% |
| 2005 | 0.09x | CN¥12.64 Million | CN¥139.78 Million | CN¥127.13 Million | ▼ -84.0% |
| 2004 | 0.57x | CN¥256.88 Million | CN¥453.72 Million | CN¥196.84 Million | ▲ +137.1% |
| 2003 | -1.52x | CN¥-227.05 Million | CN¥148.94 Million | CN¥375.98 Million | ▼ -92.5% |
| 2002 | -0.79x | CN¥-111.35 Million | CN¥140.63 Million | CN¥251.99 Million | ▼ -222.9% |
| 2001 | -0.25x | CN¥-34.57 Million | CN¥141.01 Million | CN¥175.58 Million | ▼ -149.3% |
| 2000 | 0.50x | CN¥85.98 Million | CN¥172.81 Million | CN¥86.83 Million | ▲ +6.1% |
| 1999 | 0.47x | CN¥61.67 Million | CN¥131.54 Million | CN¥69.86 Million | — |